We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors

Chris Wong Ciepiel, MD, MPH

Specialty: Pediatric Hematology and Oncology

Chris Wong Ciepiel, MD, MPH
  • Medical Director, Quality and Safety, UH Seidman Cancer Center



UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106


Chris I. Wong Quiles MD, MPH, CPPS, is a board-certified pediatric hematologist-oncologist specialist at University Hospitals Seidman Cancer Center and University Hospitals Rainbow Babies & Children’s Hospital. Her special clinical interests include the management of solid tumors in pediatric, adolescents and young adults.

Dr. Wong is the medical director of quality and safety for UH Seidman Cancer Center and for the Pediatric Hematology/Oncology Division at UH Rainbow Babies & Children’s Hospital. In this role, Dr. Wong is responsible for overseeing quality of care delivery for all patients (adult and pediatric) with hematologic and oncologic diagnosis.

Dr. Wong received her Doctor of Medicine in her home country at the University of Puerto Rico School of Medicine, receiving record-setting academic achievement and leadership awards. She completed her pediatrics residency at the Boston Combined Residency Program at Boston Children’s Hospital and Boston Medical Center. This was followed by a pediatric hematology/oncology fellowship through Harvard Medical School at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Dr. Wong completed additional training through the Harvard Medical School Fellowship in Patient Safety/Quality and became a Certified Professional in Patient Safety through the National Patient Safety Foundation and Institute for Health Care Improvement. She also received a Master’s in Public Health with a focus on Clinical Effectiveness from the Harvard T.H. Chan School of Public Health.

Dr. Wong joined UH after several years as part of the faculty at the Dana-Farber Cancer Institute and Boston Children’s Hospital, where she held leadership roles in quality and patient safety and focused on pediatric solid tumors.

Dr. Wong has been invited to present her work in quality and patient safety both nationally and internationally, with several peer-review articles published in this field. She is fluent in both English and Spanish.


  • Pediatric Hematology
  • Pediatric Oncology
  • Quality and Safety

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Boston Children's Hospital (2013 - 2016)

Residency | Pediatrics
Pediatrics - Boston Children's Hospital (2010 - 2013)

Other Education
Harvard School Of Public Health (2017)

Medical Education
University Of Puerto Rico School Of Medicine (2010)

University Of Puerto Rico (2006)

Languages Spoken

English, Spanish

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Chris Wong Ciepiel did not disclose any Outside Relationships with Industry.